21 SP's mission is to improve clinical decision making and reduce unnecessary adverse drug reactions through the use of pharmacogenetics and clinical treatment guides. Their first product, WarPhgx, is a mobile application to guide treatment for the blood thinner warfarin. It has over 110 screens to step doctors through complex decisions. Their research and development has also created a clinical decision support system incorporating information on 14 disease areas and 34 drugs. They plan to continue launching new products annually and expanding their guides to additional areas of medicine over time.